4//SEC Filing
Marvin Donald 4
Accession 0001178913-22-001179
CIK 0001534248other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 6:02 AM ET
Size
13.7 KB
Accession
0001178913-22-001179
Insider Transaction Report
Form 4
Marvin Donald
Executive VP, CFO & COO
Transactions
- Purchase
American Depositary Shares
2022-03-14$4.20/sh+250$1,050→ 1,500 total - Purchase
American Depositary Shares
2022-03-14$3.98/sh+250$995→ 500 total - Purchase
American Depositary Shares
2022-03-14$4.10/sh+250$1,025→ 1,250 total - Award
Option to Purchase American Depositary Shares
2021-11-08+196,875→ 196,875 totalExercise: $9.77Exp: 2021-11-08→ American Depositary Shares (196,875 underlying) - Purchase
American Depositary Shares
2022-03-14$4.00/sh+250$1,000→ 250 total - Purchase
American Depositary Shares
2022-03-14$3.90/sh+250$975→ 1,000 total
Footnotes (3)
- [F1]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- [F2]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F3]The options vest and become exercisable over a period of four (4) years, with one quarter (1/4) of the options vesting on November 8, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service.
Documents
Issuer
Chemomab Therapeutics Ltd.
CIK 0001534248
Entity typeother
Related Parties
1- filerCIK 0001891264
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 6:02 AM ET
- Size
- 13.7 KB